[go: up one dir, main page]

LT2000018A - Farmacinės kompozicijos, turinčios plazmos proteino - Google Patents

Farmacinės kompozicijos, turinčios plazmos proteino

Info

Publication number
LT2000018A
LT2000018A LT2000018A LT2000018A LT2000018A LT 2000018 A LT2000018 A LT 2000018A LT 2000018 A LT2000018 A LT 2000018A LT 2000018 A LT2000018 A LT 2000018A LT 2000018 A LT2000018 A LT 2000018A
Authority
LT
Lithuania
Prior art keywords
pharmaceutical compositions
compositions containing
plasma protein
containing plasma
protein
Prior art date
Application number
LT2000018A
Other languages
English (en)
Other versions
LT4736B (lt
Inventor
Lajos Hegedues
Krisztina Krempels
Krisztina Paal
Gabor Petho
Original Assignee
Human Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Rt. filed Critical Human Rt.
Publication of LT2000018A publication Critical patent/LT2000018A/lt
Publication of LT4736B publication Critical patent/LT4736B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
LT2000018A 1997-09-18 2000-03-17 Farmacinės kompozicijos, turinčios plazmos proteino LT4736B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9701554A HUP9701554D0 (en) 1997-09-18 1997-09-18 Pharmaceutical composition containing plazma proteins

Publications (2)

Publication Number Publication Date
LT2000018A true LT2000018A (lt) 2000-08-25
LT4736B LT4736B (lt) 2000-12-27

Family

ID=90014222

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2000018A LT4736B (lt) 1997-09-18 2000-03-17 Farmacinės kompozicijos, turinčios plazmos proteino

Country Status (33)

Country Link
US (5) US6743826B1 (lt)
EP (1) EP0981375B1 (lt)
JP (1) JP2001508806A (lt)
KR (1) KR100587962B1 (lt)
CN (1) CN1189216C (lt)
AR (1) AR017120A1 (lt)
AT (1) ATE230611T1 (lt)
AU (1) AU734695B2 (lt)
BG (1) BG64749B1 (lt)
BR (1) BR9812469A (lt)
CA (1) CA2269923C (lt)
CZ (1) CZ301326B6 (lt)
DE (1) DE69810612T2 (lt)
DK (1) DK0981375T3 (lt)
EA (1) EA004700B1 (lt)
ES (1) ES2187062T3 (lt)
HR (1) HRP980499A2 (lt)
HU (1) HUP9701554D0 (lt)
IL (1) IL135055A (lt)
LT (1) LT4736B (lt)
LV (1) LV12493B (lt)
NO (1) NO325294B1 (lt)
NZ (1) NZ503302A (lt)
PL (1) PL193067B1 (lt)
PT (1) PT981375E (lt)
RO (1) RO118695B1 (lt)
RS (1) RS50102B (lt)
SI (1) SI20189B (lt)
SK (1) SK284683B6 (lt)
TR (1) TR200001545T2 (lt)
TW (1) TWI222365B (lt)
WO (1) WO1999013914A1 (lt)
ZA (1) ZA988585B (lt)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
US20070092563A1 (en) * 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
AU2530700A (en) * 1999-02-11 2000-08-29 Kinetana Inc. Serum albumin-based parenteral formulations of polyene macrolides
WO2001019354A2 (en) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
MXPA02009984A (es) * 2000-04-10 2004-09-10 Teva Pharma Metodo y composicion para el tratamiento del cancer mediante la administracion de agentes quimioterapeuticos que inducen la apoptosis.
US6569459B2 (en) * 2000-04-10 2003-05-27 Teva Pharmaceutical Industries, Ltd. Method of administration of paclitaxel-plasma protein formulation
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
EP1803730A1 (en) 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
JP2004529934A (ja) * 2001-05-01 2004-09-30 アンジオテック ファーマシューティカルズ，インコーポレイテッド 抗微小管剤およびポリペプチドまたはポリサッカリドを含む組成物、ならびに炎症状態を処置するための医薬品の調製のためのそれらの組成物の使用
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
GR1004274B (el) 2002-07-16 2003-06-23 Medexis ���� Συμπλοκα στεροειδων ορμονων με πρωτεινες: νεες ουσιες για την ειδικη ανιχνευση και καταστροφη καρκινικων κυτταρων προερχομενων απο στερεους ογκους και αιματολογικες κακοηθειες
PL375363A1 (en) 2002-07-16 2005-11-28 Medexis S.A. Steroid conjugates, preparation thereof and the use thereof
AU2003262025A1 (en) * 2002-09-12 2004-04-30 Nihon Medi-Physics Co., Ltd. Preparation for controlling binging of drug to plasma protein
EP1585548B1 (en) 2002-12-09 2018-06-27 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
US20050079546A1 (en) * 2003-05-01 2005-04-14 Dasa Lipovsek Serum albumin scaffold-based proteins and uses thereof
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
US20050277584A1 (en) * 2004-06-09 2005-12-15 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US8391959B2 (en) * 2004-09-29 2013-03-05 Tel Hashomer Medical Research Infrastructure And Services Ltd. Composition for improving efficiency of drug delivery
US20060198891A1 (en) 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
RU2283133C1 (ru) * 2005-06-03 2006-09-10 Общество С Ограниченной Ответственностью "Ферон" Лечебное средство
US7507842B2 (en) 2005-08-12 2009-03-24 Radiorx, Inc. Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
EP2061440A2 (en) 2007-04-04 2009-05-27 Sigmoid Pharma Limited A pharmaceutical composition of tacrolimus
CA2942083C (en) 2007-04-26 2019-01-29 Sigmoid Pharma Limited Manufacture of multiple minicapsules
WO2009116557A1 (ja) * 2008-03-21 2009-09-24 富士フイルム株式会社 薬剤含有組成物
CN101658516B (zh) * 2008-08-26 2011-10-05 齐鲁制药有限公司 紫杉醇类药物组合物及其制备方法
CN102470106B (zh) 2009-05-18 2015-09-23 希格默伊德药业有限公司 包含油滴的组合物
CA2770570A1 (en) 2009-08-12 2011-02-17 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
US20110070293A1 (en) 2009-09-23 2011-03-24 Javeri Indu Methods for the Preparation of Liposomes Comprising Docetaxel
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
CA2784826A1 (en) * 2009-12-18 2011-06-23 Exodos Life Sciences Limited Partnership Methods and compositions for stable liquid drug formulations
CA2788663C (en) * 2010-02-03 2018-05-01 Oncbiomune, L.L.C. Taxane- and taxoid-protein compositions
AR093275A1 (es) 2010-03-17 2015-05-27 Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
AU2015232994B2 (en) 2014-03-18 2020-05-28 Izun Pharmaceuticals Corp. Protein-bound cannabinoid compositions
WO2015169944A1 (en) 2014-05-08 2015-11-12 Panoptes Pharma Ges.M.B.H. Compounds for treating ophthalmic diseases and disorders
BR112017009510A2 (pt) 2014-11-07 2017-12-19 Sigmoid Pharma Ltd composições compreendendo ciclosporina
AR100034A1 (es) 2015-01-30 2016-09-07 Consejo Nac De Investig Científicas Y Técnicas (Conicet) Una composición farmacéutica soluble en agua que comprende, al menos, una sustancia terapéuticamente activa y, al menos, una sustancia con capacidad para formar micelas
WO2016182929A1 (en) 2015-05-08 2016-11-17 Spectral Platforms, Inc. Albumin-based non-covalent complexes and methods of use thereof
CN107683134B (zh) 2015-05-15 2021-02-23 珠海贝海生物技术有限公司 多西他赛及人血清白蛋白复合物
CA2987798A1 (en) * 2015-06-18 2016-12-22 Matinas Biopharma Nanotechnologies, Inc. Compositions and methods for treating inflammatory disease or conditions
WO2017083397A1 (en) * 2015-11-09 2017-05-18 Cayo Max A Cardiac glycosides for the treatment of hypercholesterolemia
DK3402480T3 (da) 2016-01-11 2021-06-28 Epicentrx Inc Sammensætninger og fremgangsmåder til intravenøs administration af 2-brom-1-(3,3-dinitroazetidin-1-yl)ethanon
CN109789154B (zh) * 2016-08-03 2021-05-14 珠海贝海生物技术有限公司 福沙吡坦和阿瑞吡坦的制剂
CN110062622B (zh) 2016-10-27 2022-10-14 珠海贝海生物技术有限公司 多西他赛和人血清白蛋白的中性pH组合物
CA3055692A1 (en) 2017-03-09 2018-09-13 Izun Pharmaceuticals Corp. Stabilized protein-bound cannabinoid compositions
JP7134995B2 (ja) 2017-03-20 2022-09-12 スペクトラル プラットフォームス インコーポレイテッド 微生物を検出し特徴づけるための分光法
SG11201914046WA (en) 2017-07-07 2020-01-30 Epicentrx Inc Compositions for parenteral administration of therapeutic agents
WO2019164593A2 (en) 2018-01-08 2019-08-29 Epicentrx, Inc. Methods and compositions utilizing rrx-001 combination therapy for radioprotection
US12472263B2 (en) * 2018-03-09 2025-11-18 Panoptes Pharma Ges.M.B.H Ophthalmic formulation
EP3811982A1 (en) * 2019-10-25 2021-04-28 Université de Strasbourg Protein-based biomaterial with viscoelastic behaviour, process for obtaining it and uses thereof
CN115297857B (zh) 2020-02-04 2024-07-19 珠海贝海生物技术有限公司 多西他赛制剂
CN111529506B (zh) * 2020-05-18 2021-09-03 同济大学 一种两性霉素b白蛋白纳米制剂及其制备方法和应用
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
EP4267210A1 (en) 2020-12-28 2023-11-01 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
CN115997024A (zh) * 2021-06-29 2023-04-21 基因细胞生物技术公司 高效生产白蛋白的植物细胞株及其用途
CN114544926A (zh) * 2021-12-02 2022-05-27 浙江鑫科医疗科技有限公司 一种血清蛋白稳定剂
CN115236216B (zh) * 2022-06-07 2024-03-01 合肥和合医疗科技有限公司 高效液相色谱串联质谱检测全血中免疫抑制剂的试剂盒，其制备方法和检测方法
CN116212639A (zh) * 2023-02-28 2023-06-06 湖南科伦制药有限公司 一种去除药液中有机溶剂的方法及系统
CN116297963B (zh) * 2023-03-24 2024-12-27 四川汇宇制药股份有限公司 一种白蛋白结合型紫杉醇注射剂中辛酸钠含量的检测方法
CN120789284A (zh) * 2025-09-18 2025-10-17 通化安睿特生物制药股份有限公司 一种包载环孢菌素a的白蛋白结合型药物及制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4833013A (lt) * 1971-08-30 1973-05-07
DE2653534C2 (de) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung
JPS58216126A (ja) * 1982-06-11 1983-12-15 Ono Pharmaceut Co Ltd 可容化製剤
DE3702105A1 (de) * 1987-01-24 1988-08-04 Bayer Ag Parenterale loesung
WO1988006457A1 (fr) * 1987-03-04 1988-09-07 Nippon Hypox Laboratories Incorporated Composition medicinale contenant de l'albumine en tant que support et procede de preparation
JPS63215640A (ja) * 1987-03-04 1988-09-08 Nippon Hai Potsukusu:Kk 易吸収性抗炎症剤及びその製造方法
CA2086874E (en) 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
US5356927A (en) * 1992-12-02 1994-10-18 Thomas Jefferson University Methods of treating plasmodium and babesia parasitic infections
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9510716D0 (en) * 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
TR199600775A2 (tr) 1996-09-27 1997-09-21 Tureks Turunc Madencilik Ic Ve Taslara eskitilmis görüntü kazandirilmasi icin bir yöntem.
US5776912A (en) * 1996-12-20 1998-07-07 Schering Corporation Lipophilic oligosaccharide antibiotic compositions
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
ITMI20001107A1 (it) * 2000-05-18 2001-11-18 Acs Dobfar Spa Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel

Also Published As

Publication number Publication date
AU9362398A (en) 1999-04-05
AR017120A1 (es) 2001-08-22
DK0981375T3 (da) 2003-05-05
RO118695B1 (ro) 2003-09-30
LV12493A (en) 2000-06-20
DE69810612T2 (de) 2003-10-02
US20100076008A1 (en) 2010-03-25
US7501455B2 (en) 2009-03-10
CZ301326B6 (cs) 2010-01-20
DE69810612D1 (de) 2003-02-13
US6743826B1 (en) 2004-06-01
KR20010052072A (ko) 2001-06-25
US7119124B2 (en) 2006-10-10
ES2187062T3 (es) 2003-05-16
JP2001508806A (ja) 2001-07-03
IL135055A (en) 2004-09-27
BG64749B1 (bg) 2006-02-28
EP0981375B1 (en) 2003-01-08
CN1270529A (zh) 2000-10-18
BR9812469A (pt) 2002-02-05
CZ2000952A3 (cs) 2000-09-13
PL193067B1 (pl) 2007-01-31
RS50102B (sr) 2009-01-22
LV12493B (en) 2001-01-20
EA004700B1 (ru) 2004-06-24
TR200001545T2 (tr) 2000-10-23
SI20189A (sl) 2000-10-31
TWI222365B (en) 2004-10-21
HUP9701554D0 (en) 1997-11-28
WO1999013914A1 (en) 1999-03-25
AU734695B2 (en) 2001-06-21
NO20001371L (no) 2000-05-18
PT981375E (pt) 2003-04-30
US20070232536A1 (en) 2007-10-04
CA2269923C (en) 2003-07-22
NO325294B1 (no) 2008-03-17
ATE230611T1 (de) 2003-01-15
US8946167B2 (en) 2015-02-03
PL339369A1 (en) 2000-12-18
US20040014655A1 (en) 2004-01-22
IL135055A0 (en) 2001-05-20
ZA988585B (en) 2000-03-13
NZ503302A (en) 2001-08-31
SK3292000A3 (en) 2000-08-14
LT4736B (lt) 2000-12-27
HRP980499A2 (en) 1999-12-31
NO20001371D0 (no) 2000-03-16
KR100587962B1 (ko) 2006-06-13
CN1189216C (zh) 2005-02-16
SK284683B6 (sk) 2005-09-08
EP0981375A1 (en) 2000-03-01
US20050064028A1 (en) 2005-03-24
EA200000331A1 (ru) 2000-10-30
BG104245A (en) 2000-11-30
SI20189B (sl) 2007-10-31
CA2269923A1 (en) 1999-03-25
YU16600A (sh) 2003-08-29

Similar Documents

Publication Publication Date Title
IL135055A0 (en) Pharmaceutical compositions containing plasma protein
GB9727053D0 (en) Pharmaceutical compositions
GB9706089D0 (en) Pharmaceutical composition
IL133928A0 (en) Pharmaceutical composition containing peptichemio
IL114673A0 (en) Pharmaceutical compositions containing protein
AU5384699A (en) Basic peptides and pharmaceutical compositions containing same
GB9717444D0 (en) Pharmaceutical composition
IL131917A0 (en) Pharmaceutical compositions
IL131995A0 (en) Gastric-retained pharmaceutical compositions
GB9723985D0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
GB9726735D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
AU8817498A (en) Pharmaceutical composition containing midazolam
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
GB9718270D0 (en) Pharmaceutical compositions
HU9802107D0 (en) Pharmaceutical composition containing plazma proteins
IL110319A0 (en) Pharmaceutical compositions containing protein
GB9710505D0 (en) Pharmaceutical compositions
GB9714328D0 (en) Pharmaceutical compositions
GB9710527D0 (en) Pharmaceutical compositions
GB9722066D0 (en) Pharmaceutical compositions
GB9725563D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PC9A Transfer of patents

Owner name: TEVA PHARMACEUTICAL WORKS PLC, HU

Effective date: 20060620

MK9A Expiry of a patent

Effective date: 20180917